Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Friday. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Performance

Shares of NYSE RVP opened at $0.68 on Friday. The company has a 50-day simple moving average of $0.77 and a 200-day simple moving average of $0.73. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. The company has a market cap of $20.36 million, a PE ratio of -1.26 and a beta of 2.28. Retractable Technologies has a 12 month low of $0.56 and a 12 month high of $1.22.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Retractable Technologies stock. Renaissance Technologies LLC increased its holdings in shares of Retractable Technologies, Inc. (NYSE:RVP) by 9.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 361,253 shares of the company’s stock after buying an additional 31,140 shares during the quarter. Renaissance Technologies LLC owned about 1.21% of Retractable Technologies worth $249,000 as of its most recent filing with the Securities and Exchange Commission. 7.58% of the stock is currently owned by institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.